Clinical Trial Update: Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update on TOOKAD VTP for low risk prostate cancer; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TOOKAD (padeliparvovec? (Note: TOOKAD is verteporfin-based vascular-targeted photodynamic therapy).)

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Low Risk Prostate Cancer | Phase 4 | Status: TERMINATED